Free Trial

Auna (AUNA) Expected to Announce Quarterly Earnings on Tuesday

Auna logo with Medical background

Key Points

  • Auna (NYSE:AUNA) is set to release its Q2 2025 earnings data on Tuesday, August 19th, with analysts predicting earnings of $0.16 per share and revenue of $1.17 billion.
  • $0.19 per share, surpassing estimates, and generated revenue of $281.43 million.
  • Analysts have recently downgraded Auna's stock from a "buy" to a "hold" rating, with HSBC setting a price target of $7.90 for the shares.
  • Need better tools to track Auna? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Auna (NYSE:AUNA - Get Free Report) is expected to post its Q2 2025 quarterly earnings results after the market closes on Tuesday, August 19th. Analysts expect Auna to post earnings of $0.16 per share and revenue of $1.17 billion for the quarter.

Auna (NYSE:AUNA - Get Free Report) last issued its earnings results on Tuesday, May 20th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.03. The company had revenue of $281.43 million during the quarter, compared to analyst estimates of $1.12 billion. Auna had a net margin of 3.67% and a return on equity of 10.39%. During the same quarter last year, the business posted $0.10 EPS. On average, analysts expect Auna to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Auna Stock Down 0.2%

Shares of NYSE:AUNA traded down $0.01 during trading on Friday, reaching $6.31. 22,332 shares of the company traded hands, compared to its average volume of 20,528. The company has a quick ratio of 0.78, a current ratio of 0.83 and a debt-to-equity ratio of 1.76. Auna has a 1-year low of $6.09 and a 1-year high of $9.24. The firm has a fifty day simple moving average of $6.29 and a 200 day simple moving average of $6.97. The firm has a market cap of $467.00 million, a P/E ratio of 10.88 and a beta of 2.25.

Analyst Ratings Changes

Several equities research analysts recently issued reports on AUNA shares. HSBC set a $7.90 price objective on shares of Auna and gave the company a "hold" rating in a research note on Thursday, May 22nd. Wall Street Zen lowered shares of Auna from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Finally, Hsbc Global Res raised shares of Auna to a "hold" rating in a research note on Thursday, May 22nd.

View Our Latest Report on AUNA

Institutional Investors Weigh In On Auna

A hedge fund recently bought a new stake in Auna stock. Goldman Sachs Group Inc. bought a new position in shares of Auna S.A. (NYSE:AUNA - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 30,738 shares of the company's stock, valued at approximately $219,000.

About Auna

(Get Free Report)

Auna SA, a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare plans in Peru; and dental and vision plans in Mexico. The company was founded in 1989 and is based in Luxembourg, Luxembourg.

Featured Articles

Should You Invest $1,000 in Auna Right Now?

Before you consider Auna, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Auna wasn't on the list.

While Auna currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines